MicroRNAs and cancer; an overview

Current Pharmaceutical Biotechnology

Volumn 15, Issue 5, 2014, Pages 430-437

  Tutar, Lütfi ^a   Tutar, Esen ^a   Tutar, Yusuf ^b  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Biomarkers; Cancer; MicroRNAs; Therapeutics

Indexed keywords

ALPHA TROPOMYOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LYMPHOCYTE ANTIGEN; MASPIN; MICRORNA; MICRORNA 106A; MICRORNA 126; MICRORNA 143; MICRORNA 145; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 182; MICRORNA 200; MICRORNA 21; MICRORNA 29; PROGRAMMED DEATH 4 RECEPTOR; UNCLASSIFIED DRUG; TUMOR MARKER;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BIOGENESIS; BRAIN TUMOR; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; DOWN REGULATION; GENE CONTROL; GENE DELETION; GENE FUNCTION; GLIOBLASTOMA; HUMAN; LUNG CANCER; NEOPLASM; NON SMALL CELL LUNG CANCER; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; UPREGULATION; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; NEOPLASMS; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907161197     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140519095304     Document Type: Article

References (123)

1. Lee, R. C.; Feinbaum, R. L.; Ambros, V. The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense com plementarity to lin-14. Cell, 1993, 75(5), 843-854.
2. Reinhart, B.; Slack, F.; Basson, M.; Pasquinelli, A.; Bettinger, J.; Rougvie, A.; Horvitz, R.; Ruvkun, G. The 21 nucleotide let-7 RNA regulates C. elegans developmental timing. Nature, 2000, 403(6772), 901-906.
3. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2), 281-297.
4. He, L.; Hannon, G. J. MicroRNAs: Small RNAs with a big role in gene regulation. Nature Rev. Genetics, 2004, 5(7), 522-531.
5. Lee, Y.; Kim, M.; Han, J.; Yeom, K. H.; Lee, S.; Baek, S. H.; Kim, V. N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 2004, 23(20), 4051-4060.
6. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim. J.; Yim, J.; Lee, J.; Provost, P.; Radmark, O.; Kim, S.; Kim, V. N. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003, 425(6956), 415-419.
7. Denli, A. M.; Tops, B. B.; Plasterk, R. H.; Ketting, R. F.; Hannon, G. J. Processing of primary microRNAs by the Microprocessor complex. Nature, 2004, 432(7014), 231-235.
8. Bohnsack, M. T.; Czaplinski, K.; Gorlich, D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA, 2004, 10(2), 185-191.
9. Lund, E.; Guttinger, S.; Calado, A.; Dahlberg, J. E.; Kutay, U. Nuclear export of microRNA precursors. Science, 2004, 303(5654), 95-98.
10. Hammond, S. M.; Bernstein, E.; Beach, D.; Hannon, G. J. An RNA directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 2000, 404(6775), 293-296.
11. Chendrimada, T. P.; Gregory, R. I.; Kumaraswamy, E.; Norman, J.; Cooch, N.; Nishikura, K.; Shiekhattar, R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 2005, 436(7051), 740-744.
12. Diederichs, S.; Haber, D. A. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell, 2007, 131(6), 1097-1108.
13. Chiang, H. R.; Schoenfeld, L. W.; Ruby, J. G.; Auyeung, V. C.; Spies, N.; Baek, D.; Johnston, W. K.; Russ, C.; Luo, S.; Babiarz, J. E.; Blelloch, R.; Schroth, G. P.; Nusbaum, C.; Bartel, D. P. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev., 2010, 24(10), 992-1009.
14. Orom, U. A.; Nielsen, F. C.; Lund, A. H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell, 2008, 30(4), 460-471.
15. Qin, W.; Shi, Y.; Zhao, B.; Yao, C.; Jin, L.; Ma, J.; Jin, Y. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One, 2010, 5, e9429.
16. Calin, G. A.; Dumitru, C. D.; Shimizu, M.; Bichi, R.; Zupo, S.; Noch, E.; Aldler, H.; Rattan, S.; Keating, M.; Rai, K.; Rassenti, L.; Kipps, T.; Negrini, M.; Bullrich, F.; Croce, C. M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. PNAS, 2002, 99(24), 15524-15533.
17. Johnson, S. M.; Grosshans, H.; Shingara, J.; Byrom, M.; Jarvis, R.; Cheng, A.; Labourier, E.; Reinert, K. L.; Brown, D.; Slack, F. J. RAS is regulated by the let-7 microRNA family. Cell, 2005, 120(5), 635-647.
18. Lee, Y. S.; Dutta, A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev., 2007, 21(9), 1025-1030.
19. Mayr, C.; Hemann, M. T.; Bartel, D. P. Disrupting the pairing between let-7 and hmga2 enhances oncogenic transformation. Science, 2007, 315(5818), 1576-1579.
20. Park, S. M.; Shell, S.; Radjabi, A. R.; Schickel, R.; Feig, C.; Boyerinas, B.; Dinulescu, D. M.; Lengyel, E.; Peter, M. E. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle, 2007, 6(21), 2585-2590.
21. Peng, Y.; Laser, J.; Shi, G.; Mittal, K.; Melamed, J.; Lee, P.; Wei, J. J. Antiproliferative effects by let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol. Cancer Res., 2008, 6(4), 663-673.
22. Sampson, V. B.; Rong, N. H.; Han, J.; Yang, Q.; Aris, V.; Soteropoulos, P.; Petrelli, N. J.; Dunn, S. P.; Krueger, L. J. MicroRNA let-7a down-regulates MYC and reverts MYC induced growth in burkitt lymphoma cells. Cancer Res., 2007, 67(20), 9762-9770.
23. Muller, D. W.; Bosserhoff, A. K. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene, 2008, 27(52), 6698-6706.
24. Boyerinas, B.; Park, S. M.; Shomron, N.; Hedegaard, M. M.; Vinther, J.; Andersen, J. S.; Feig, C.; Xu, J.; Burge, C. B.; Peter, M. E. Identification of let-7-regulated oncofetal genes. Cancer Res., 2008, 68(8), 2587-2591.
25. Forman, J. J.; Legesse-Miller, A.; Coller, H. A. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets dicer within its coding sequence. Proc. Natl. Acad. Sci. USA, 2008, 105(39), 14879-14884.
26. Toyota, M.; Suzuki, H.; Sasaki, Y.; Maruyama, R.; Imai, K.; Shinomura, Y.; Tokino, T. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res., 2008, 68(11), 4123-41232.
27. Michael, M. Z.; O'Connor, S. M.; van Holst Pellekaan, N. G.; Young, G. P.; James, R. J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 2003, 1(12), 882-891.
28. Volinia, S.; Galasso, M.; Costinean, S.; Tagliavini, L.; Gamberoni, G.; Drusco, A.; Marchesini, J.; Mascellani, N.; Sana, M. E.; Abu Jarour, R.; Desponts, C.; Teitell, M.; Baffa, R.; Aqeilan, R.; Iorio, M. V.; Taccioli, C.; Garzon, R.; Di Leva, G.; Fabbri, M.; Catozzi, M.; Previati, M.; Ambs, S.; Palumbo, T.; Garofalo, M.; Veronese, A.; Bottoni, A.; Gasparini, P.; Harris, C. C.; Visone, R.; Pekarsky, Y.; de la Chapelle, A.; Bloomston, M.; Dillhoff, M.; Rassenti, L. Z.; Kipps, T. J.; Huebner, K.; Pichiorri, F.; Lenze, D.; Cairo, S.; Buendia, M. A.; Pineau, P.; Dejean, A.; Zanesi, N.; Rossi, S.; Calin, G. A.; Liu, C. G.; Palatini, J.; Negrini, M.; Vecchione, A.; Rosenberg, A.; Croce, C. M. Reprogramming of miRNA networks in cancer and leukemia. Genome Res., 2010, 20(5), 589-599.
29. Calin, G. A.; Ferracin, M.; Cimmino, A.; Di Leva, G.; Shimizu, M.; Wojcik, S. E.; Iorio, M. V.; Visone, R.; Sever, N. I.; Fabbri, M.; Iuliano, R.; Palumbo, T.; Pichiorri, F.; Roldo, C.; Garzon, R.; Sevignani, C.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. M. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 2005, 353(17), 1793-1801.
30. Garzon, R.; Volinia, S.; Liu, C. G.; Fernandez-Cymering, C.; Palumbo, T.; Pichiorri, F.; Fabbri, M.; Coombes, K.; Alder, H.; Nakamura, T.; Flomenberg, N.; Marcucci, G.; Calin, G. A.; Kornblau, S. M.; Kantarjian, H.; Bloomfield, C. D.; Andreeff, M.; Croce, C. M. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood, 2008, 111(6), 3183-3189.
31. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA, 2006, 103(7), 2257-2261.
32. Garzon, R.; Garofalo, M.; Martelli, M. P.; Briesewitz, R.; Wang, L.; Fernandez-Cymering, C.; Volinia, S.; Liu, C. G.; Schnittger, S.; Haferlach, T.; Liso, A.; Diverio, D.; Mancini, M.; Meloni, G.; Foa, R.; Martelli, M. F.; Mecucci, C.; Croce, C. M.; Falini, B. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc. Natl. Acad. Sci. USA, 2008, 105(10), 3945-3950.
33. Ciafre, S. A.; Galardi, S.; Mangiola, A.; Ferracin, M.; Liu, C. G.; Sabatino, G.; Negrini, M.; Maira, G.; Croce, C. M.; Farace, M. G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun., 2005, 334(4), 1351-1358.
34. Chan, J. A.; Krichevsky, A. M.; Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 2005, 65(14), 6029-6033.
35. Meng, F.; Henson, R.; Wehbe-Janek, H.; Ghoshal, K.; Jacob, S. T.; Patel, T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007, 133(2), 647-658.
36. Frankel, L. B.; Christoffersen, N. R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A. H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 2008, 283(2), 1026-1033.
37. Zhu, S.; Si, M. L.; Wu, H.; Mo, Y. Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem., 2007, 282(19), 14328-14336.
38. Mendel, J. T. miRiad roles for the miR-17-92 cluster in development and disease. Cell, 2008, 133(2), 217-222.
39. O'Donnell, K. A.; Wentzel, E. A.; Zeller, K. I.; Dang, C. V.; Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 2005, 435(7043), 839-843.
40. Iorio, M. V.; Ferracin, M.; Liu, C. G.; Veronese, A.; Spizzo, R.; Sabbioni, S.; Magri, E.; Pedriali, M.; Fabbri, M.; Campiglio, M.; Ménard, S.; Palazzo, J. P.; Rosenberg, A.; Musiani, P.; Volinia, S.; Nenci, I.; Calin, G. A.; Querzoli, P.; Negrini, M.; Croce, C. M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 2005, 65(16), 7065-7070.
41. Metzler, M.; Wilda, M.; Busch, K.; Viehmann, S.; Borkhardt, A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer, 2004, 39(2), 167-169.
42. He, H.; Jazdzewski, K.; Li, W.; Liyanarachchi, S.; Nagy, R.; Volinia, S.; Calin, G. A.; Liu, C. G.; Franssila, K.; Suster, S.; Kloos, R. T.; Croce, C. M.; de la Chapelle, A. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA, 2005, 102(52), 19075-19080.
43. Takamizawa, J.; Konishi, H.; Yanagisawa, K.; Tomida, S.; Osada, H.; Endoh, H.; Harano, T.; Yatabe, Y.; Nagino, M.; Nimura, Y.; Mitsudomi, T.; Takahashi, T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 2004, 64(11), 3753-3756.
44. Hayashita, Y.; Osada, H.; Tatematsu, Y.; Yamada, H.; Yanagisawa, K.; Tomida, S.; Yatabe, Y.; Kawahara, K.; Sekido, Y.; Takahashi, T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res., 2005, 65(21), 9628-9632.
45. Murakami, Y.; Yasuda, T.; Saigo, K.; Urashima, T.; Toyoda, H.; Okanoue, T.; Shimotohno, K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and nontumorous tissues. Oncogene, 2006, 25(17), 2537-2545.
46. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009. CA Cancer J. Clin., 2009, 59(4), 225-249.
47. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA Cancer J. Clin., 2010, 60(5), 277-300.
48. Kamangar, F.; Dores, G. M.; Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol., 2006, 24(14), 2137-2150.
49. Yanaihara, N.; Caplen, N.; Bowman, E.; Seike, M.; Kumamoto, K.; Yi, M.; Stephens, R. M.; Okamoto, A.; Yokota, J.; Tanaka, T.; Calin, G. A.; Liu, C. G.; Croce, C. M.; Harris, C. C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9(3), 189-198.
50. Esquela-Kerscher, A.; Trang, P.; Wiggins, J. F.; Patrawala, L.; Cheng, A.; Ford, L.; Weidhaas, J. B.; Brown, D.; Bader, A. G.; Slack, F. J. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle, 2008, 7(6), 759-764.
51. Trang, P.; Medina, P. P.; Wiggins, J. F.; Ruffino, L.; Kelnar, K.; Omotola, M.; Homer, R.; Brown, D.; Bader, A. G.; Weidhaas, J. B.; Slack, F. J. Regression of murine lung tumors by the let-7 microRNA. Oncogene, 2010, 29(11), 1580-1587.
52. Seike, M.; Goto, A.; Okano, T.; Bowman, E. D.; Schetter, A. J.; Horikawa, I.; Mathe, E. A.; Jen, J.; Yang, P.; Sugimura, H.; Gemma, A.; Kudoh, S.; Croce, C. M.; Harris, C. C. MiR-21 is an EGFR regulated anti-apoptotic factor in lung cancer in never smokers. Proc. Natl. Acad. Sci. USA, 2009, 106(29), 12085-90.
53. Frezzetti, D.; De Menna, M.; Zoppoli, P.; Guerra, C.; Ferraro, A.; Bello, A. M.; De Luca, P.; Calabrese, C.; Fusco, A.; Ceccarelli, M.; Zollo, M.; Barbacid, M.; Di Lauro, R.; De Vita, G. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene, 2011, 30(3), 275-286.
54. Yu, F.; Yao, H.; Zhu, P.; Zhang, X.; Pan, Q.; Gong, C.; Huang, Y.; Hu, X.; Su, F.; Lieberman, J.; Song, E. let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell, 2007, 131(6), 1109-123.
55. Shimono, Y.; Zabala, M.; Cho, R. W.; Lobo, N.; Dalerba, P.; Qian, D.; Diehn, M.; Liu, H.; Panula, S. P.; Chiao, E.; Dirbas, F. M.; Somlo, G.; Pera, R. A.; Lao, K.; Clarke, M. F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 2009, 138(3), 592-603.
56. Spizzo, R.; Nicoloso, M. S.; Lupini, L.; Lu, Y.; Fogarty, J.; Rossi, S.; Zagatti, B.; Fabbri, M.; Veronese, A.; Liu, X.; Davuluri, R.; Croce, C. M.; Mills, G.; Negrini, M.; Calin, G. A. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ., 2010, 17(2), 246-254.
57. Sachdeva, M.; Mo, Y. Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res., 2010, 70(1), 378-387.
58. Si, M. L.; Zhu, S.; Wu, H.; Lu, Z.; Wu, F.; Mo, Y. Y. miR-21-mediated tumor growth. Oncogene, 2007, 26(19), 2799-2803.
59. Zhu, S.; Wu, H.; Wu, F.; Nie, D.; Sheng, S.; Mo, Y. Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res., 2008, 18(3), 350-359.
60. Mertens-Talcott, S. U.; Chintharlapalli, S.; Li, X.; Safe, S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDAMB-231 breast cancer cells. Cancer Res., 2007, 67(22), 11001-11011.
61. Li, X.; Mertens-Talcott, S. U.; Zhang, S.; Kim, K.; Ball, J.; Safe, S. MicroRNA-27a indirectly regulates estrogen receptor α expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology, 2010, 151(6), 2462-2473.
62. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin., 2012, 62(1); 10-29.
63. Akao, Y.; Nakagawa, Y.; Naoe, T. MicroRNAs143and 145 are possible common onco-microRNAs in human cancers. Oncol. Rep., 2006, 16(4), 845-850.
64. Slaby, O.; Svoboda, M.; Fabian, P.; Smerdova, T.; Knoflickova, D.; Bednarikova, M.; Nenutil, R.; Vyzula, R. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinic pathologic features of colorectal cancer. Oncology, 2007, 72(5-6), 397-402.
65. Wang, H.; Wu, J.; Meng, X.; Ying, X.; Zuo, Y.; Liu, R.; Pan, Z.; Kang, T.; Huang, W. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis, 2011, 32(7), 1033-1042.
66. Motoyama, K.; Inoue, H.; Takatsuno, Y.; Tanaka, F.; Mimori, K.; Uetake, H.; Sugihara, K.; Mori, M. Over-and under-expressed microRNAs in human colorectal cancer. Int. J. Oncol., 2009, 34(4), 1069-1075.
67. Chen, X.; Guo, X.; Zhang, H.; Xiang, Y.; Chen, J.; Yin, Y.; Cai, X.; Wang, K.; Wang, G.; Ba, Y.; Zhu, L.; Wang, J.; Yang, R.; Zhang, Y.; Ren, Z.; Zen, K.; Zhang, J.; Zhang, C. Y. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene, 2009, 28(10), 1385-1392.
68. Earle, J. S.; Luthra, R.; Romans, A.; Abraham, R.; Ensor, J.; Yao, H.; Hamilton, S. R. Association of MicroRNA Expression with Microsatellite Instability Status in Colorectal Adenocarcinoma. J. Mol. Diagn., 2010, 12(4), 433-440.
69. Ng, E. K.; Tsang, W. P.; Ng, S. S.; Jin, H. C.; Yu, J.; Li, J. J.; Röcken, C.; Ebert, M. P.; Kwok, T. T.; Sung, J. J. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer, 2009, 101(4), 699-706.
70. Akao, Y.; Nakagawa, Y.; Naoe, T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 2006, 29(5), 903-906.
71. Han, H. B.; Gu, J.; Zuo, H. J.; Chen, Z. G.; Zhao, W.; Li, M.; Ji, D. B.; Lu, Y. Y.; Zhang, Z. Q. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J. Pathol., 2012, 226(3), 544-555.
72. Wang, F.; Zhang, P.; Ma, Y.; Yang, J.; Moyer, M. P.; Shi, C.; Peng, J.; Qin, H. NIRF is frequently up regulated in colorectal cancer and its oncogenicity can be suppressed bylet-7a microRNA. Cancer Lett., 2012, 314(2), 223-231.
73. Chen, M. L.; Liang, L. S.; Wang, X. K. miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. Clin. Exp. Metastasis, 2012, 29(5), 457-469.
74. Asangani, I. A.; Rasheed, S. A.; Nikolova, D. A.; Leupold, J. H.; Colburn, N. H.; Post, S.; Allgayer, H. MicroRNA-21 (miR-21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 2008, 27(15), 2128-2136.
75. Link, A.; Balaguer, F.; Shen, Y.; Nagasaka, T.; Lozano, J. J.; Boland, C. R.; Goel, A. Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol. Biomarkers Prev., 2010, 19(7), 1766-1774.
76. Jongen-Lavrencic, M.; Sun, S. M.; Dijkstra, M. K.; Valk, P. J.; Lowenberg, B. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood, 2008, 111(10), 5078-5085.
77. Garzon, R.; Heaphy, C. E.; Havelange, V.; Fabbri, M.; Volinia, S.; Tsao, T.; Zanesi, N.; Kornblau, S. M.; Marcucci, G.; Calin, G. A.; Andreeff, M.; Croce, C. M. MicroRNA 29b functions in acute myeloid leukemia. Blood, 2009, 114(26), 5331-5341.
78. Pekarsky, Y.; Santanam, U.; Cimmino, A.; Palamarchuk, A.; Efanov, A.; Maximov, V.; Volinia, S.; Alder, H.; Liu, C. G.; Rassenti, L., Calin, G. A.; Hagan, J. P.; Kipps, T.; Croce, C. M. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res., 2006, 66(24), 11590-11593.
79. Li, Z.; Lu, J.; Sun, M.; Mi, S.; Zhang, H.; Luo, R. T.; Chen, P.; Wang, Y.; Yan, M.; Qian, Z.; Neilly, M. B.; Jin, J.; Zhang, Y.; Bohlander, S. K.; Zhang, D. E.; Larson, R. A.; Le Beau, M. M.; Thirman, M. J.; Golub, T. R.; Rowley, J. D.; Chen, J. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. USA, 2008, 105(40), 15535-15540.
80. Zaidi, S. K.; Dowdy, C. R.; van Wijnen, A. J.; Lian, J. B.; Raza, A.; Stein, J. L.; Croce, C. M.; Stein, G. S. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. Cancer Res., 2009, 69(21), 8249-8255.
81. Bousquet, M.; Harris, M. H.; Zhou, B.; Lodish, H. F. MicroRNA miR-125b causes leukemia. Proc. Natl. Acad. Sci. USA, 2010, 107(50), 21558-21563.
82. Wang, M.; Tan, L. P.; Dijkstra, M. K.; van Lom, K.; Robertus, J. L.; Harms, G.; Blokzijl, T.; Kooistra, K.; van T'veer, M. B.; Rosati, S.; Visser, L.; Jongen-Lavrencic, M.; Kluin, P. M.; van den Berg, A. miRNA analysis in B-cell chronic lymphocytic leukaemia: Proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J. Pathol., 2008, 215(1), 13-20.
83. Mavrakis, K. J.; Wolfe, A. L.; Oricchio, E.; Palomero, T.; de Keersmaecker, K.; McJunkin, K.; Zuber, J.; James, T.; Khan, A. A.; Leslie, C. S.; Parker, J. S.; Paddison, P. J.; Tam, W.; Ferrando, A.; Wendel, H. G. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat. Cell Biol., 2010, 12(4), 372-379.
84. Medina, P. P.; Nolde, M.; Slack, F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 2010, 467(7311), 86-90.
85. Tsai, W. C.; Hsu, P. W.; Lai, T. C.; Chau, G. Y.; Lin, C. W.; Chen, C. M., Lin, C. D.; Liao, Y. L.; Wang, J. L.; Chau, Y. P.; Hsu, M. T.; Hsiao, M.; Huang, H. D., Tsou, A. P. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology, 2009, 49(5), 1571-1582.
86. Yoon, S. O.; Chun, S. M.; Han, E. H.; Choi, J.; Jang, S. J.; Koh, S. A.; Hwang, S.; Yu, E. Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. Human Pathol., 2011, 42(10), 1391-1400.
87. Roldo, C.; Missiaglia, E.; Hagan, J. P.; Falconi, M.; Capelli, P.; Bersani, S.; Calin, G. A.; Volinia, S.; Liu, C. G.; Scarpa, A.; Croce, C. M. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol., 2006, 24(29), 4677-4684.
88. Ali, S.; Saleh, H.; Sethi, S.; Sarkar, F. H.; Philip, P. A. MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Brit. J. Cancer, 2012, 107(8), 1354-1360.
89. Moriyama, T.; Ohuchida, K.; Mizumoto, K.; Yu, J.; Sato, N.; Nabae, T.; Takahata, S.; Toma, H.; Nagai E.; Tanaka, M. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Molecul. Cancer Therapeut., 2009, 8(5), 1067-1074.
90. Zhang, X. J.; Ye, H.; Zeng, C. W.; He, B.; Zhang, H.; Chen, Y. Q. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J. Hematol. Oncol., 2010, 24, 3-46.
91. Yang, Z.; Chen, S.; Luan, X.; Li, Y.; Liu, M.; Li, X.; Liu, T.; Tang, H. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life, 2009, 61(11), 1075-1082.
92. Bottoni, A.; Piccin, D.; Tagliati, F.; Luchin, A.; Zatelli, M. C.; degli Uberti, E. C. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J. Cellular Physiol., 2005, 204(1), 280-285.
93. Mitchell, P. S.; Parkin, R. K.; Kroh, E. M.; Fritz, B. R.; Wyman, S. K.; Pogosova-Agadjanyan, E. L.; Peterson, A.; Noteboom, J.; O'briant, K. C.; Allen, A.; Lin, D. W.; Urban, N.; Drescher, C. W.; Knudsen, B. S.; Stirewalt, D. L.; Gentleman, R.; Vessella, R. L.; Nelson, P. S.; Martin, D. B.; Tewari, M. Circulating microRNAs as stable bloodbased markers for cancer detection. Proc. Natl. Acad. Sci. USA, 2008, 105(30), 10513-10518.
94. Pineles, B. L.; Romero, R.; Montenegro, D.; Tarca, A. L.; Han, Y. M.; Kim, Y. M.; Draghici, S.; Espinoza, J.; Kusanovic, J. P.; Mittal, P.; Hassan, S. S.; Kim, C. J. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Amer. J. Obstet. Gynecology, 2007, 196(261), e1-e6.
95. Dahiya, N.; Sherman-Baust, C. A.; Wang, T. L.; Davidson, B.; Shih, L.; Zhang, Y.; Wood III, W.; Becker, K. G.; Morin, P. J. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One, 2008, 3, e2436.
96. Lu, J.; Getz, G.; Miska, E. A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B. L.; Mak, R. H.; Ferrando, A. A.; Downing, J. R.; Jacks, T.; Horvitz, H. R.; Golub, T. R. MicroRNA expression profiles classify human cancers. Nature, 2005, 435(7043), 834-838.
97. Hui, A. B.; Shi, W.; Boutros, P. C.; Miller, N.; Pintilie, M.; Fyles, T.; McCready, D.; Wong, D.; Gerster, K.; Waldron, L.; Jurisica, I.; Penn, L. Z.; Liu, F. F. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest., 2009, 89(5), 597-606.
98. Weber, J. A.; Baxter, D. H.; Zhang, S.; Huang, D. Y.; Huang, K. H.; Lee, M. J.; Galas, D. J.; Wang, K. The microRNA spectrum in 12 body fluids. Clin. Chem., 2010, 56(11), 1733-1741.
99. Lawrie, C. H.; Gal, S.; Dunlop, H. M.; Pushkaran, B.; Liggins, A. P.; Pulford, K.; Banham, A. H.; Pezzella, F.; Boultwood, J.; Wainscoat, J. S.; Hatton, C. S.; Harris, A. L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol., 2008, 141(5), 672-675.
100. Cortez, M. A.; Bueso-Ramos, C.; Ferdin, J.; Lopez-Berestein, G.; Sood, A. K.; Calin, G. A. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol., 2011, 8(8), 467-477.
101. Zhu, W.; Qin, W.; Atasoy, U.; Sauter, E. R. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes, 2009, 2, 89.
102. Zhao, H.; Shen, J.; Medico, L.; Wang, D.; Ambrosone, C. B.; Liu, S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One, 2010, 5(10), e13735.
103. Asaga, S.; Kuo, C.; Nguyen, T.; Terpenning, M.; Giuliano, A. E.; Hoon, D. S. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin. Chem., 2011, 57(1), 84-91.
104. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X.; Li, Q.; Li, X.; Wang, W.; Zhang, Y.; Wang, J.; Jiang, X.; Xiang, Y.; Xu, C.; Zheng, P.; Zhang, J.; Li, R.; Zhang, H.; Shang, X.; Gong, T.; Ning, G.; Wang, J.; Zen, K.; Zhang, J.; Zhang, C. Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res., 2008, 18(10), 997-1006.
105. Wang, T.; Lv, M.; Shen, S.; Zhou, S.; Wang, P.; Chen, Y.; Liu, B.; Yu, L.; Hou, Y. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS One, 2012, 7(8), e43268.
106. Liu, C. J.; Lin, S. C.; Yang, C. C.; Cheng, H. W.; Chang, K. W. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck, 2012, 34(2), 219-224.
107. Hanke, M.; Hoefig, K.; Merz, H.; Feller, A. C.; Kausch, I.; Jocham, D.; Warnecke, J. M.; Sczakiel, G. A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol., 2010, 28(6), 655-661.
108. Xie, L.; Chen, X.; Wang, L.; Qian, X.; Wang, T.; Wei, J.; Yu, L.; Ding, Y.; Zhang, C.; Liu, B.; Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer, 2010, 10, 591.
109. Ng, E. K.; Chong, W. W.; Jin, H.; Lam, E. K.; Shin, V. Y.; Yu, J.; Poon, T. C.; Ng, S. S.; Sung, J. J. Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut, 2009, 58(10), 1375-1381.
110. Huang, Z.; Huang, D.; Ni, S.; Peng, Z.; Sheng, W.; Du, X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer, 2010, 127(1), 118-126.
111. Yamamoto, Y.; Kosaka, N.; Tanaka, M.; Koizumi, F.; Kanai, Y.; Mizutani, T.; Murakami, Y.; Kuroda, M.; Miyajima, A.; Kato, T.; Ochiva, T. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers, 2009, 14(7), 529-538.
112. Qu, K. Z.; Zhang, K.; Li, H.; Afdhal, N. H.; Albitar, M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J. Clin. Gastroenterol., 2011, 45(4), 355-360.
113. Taylor, D. D.; Gercel-Taylor, C. MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol., 2008, 110(1), 13-21.
114. Resnick, K. E.; Alder, H.; Hagan, J. P.; Richardson, D. L.; Croce, C. M.; Cohn, D. E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol., 2009, 112(1), 55-59.
115. Li, A.; Omura, N.; Hong, S. M.; Vincent, A.; Walter, K.; Griffith, M.; Borges, M.; Goggins, M. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res., 2010, 70(13), 5226-5237.
116. Ho, A. S.; Huang, X.; Cao, H.; Christman-Skieller, C.; Bennewith, K.; Le, Q. T.; Koong, A. C. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl. Oncol., 2010, 3(2), 109-113.
117. Morimura, R.; Komatsu, S.; Ichikawa, D.; Takeshita, H.; Tsujiura, M.; Nagata, H.; Konishi, H.; Shiozaki, A.; Ikoma, H.; Okamoto, K.; Ochiai, T.; Taniguchi, H.; Otsuji, E. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br. J. Cancer, 2011, 105(11), 1733-1740.
118. Bader, A. G.; Brown, D.; Winkler, M. The promise of microRNA replacement therapy. Cancer Res., 2010, 70(18), 7027-7030.
119. Mei, M.; Ren, Y.; Zhou, X.; Yuan, X. B.; Han, L.; Wang, G. X.; Jia, Z.; Pu, P. Y.; Kang, C. S.; Yao, Z. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol. Cancer Res. Treat., 2010, 9(1), 77-86.
120. Corsten, M. F.; Miranda, R.; Kasmieh, R.; Krichevsky, A. M.; Weissleder, R.; Shah, K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res., 2007, 67(19), 8994-9000.
121. Gumireddy, K.; Young, D. D.; Xiong, X.; Hogenesch, J. B.; Huang, Q.; Deiters, A. Small-molecule inhibitors of microrna miR-21 function. Angew Chem. Int. Ed Engl., 2008, 47(39), 7482-7484.
122. Wiggins, J. F.; Ruffino, L.; Kelnar, K.; Omotola, M.; Patrawala, L.; Brown, D.; Bader, A. G. Development of a lung cancer therapeutic based on the tumour suppressor microRNA-34. Cancer Res., 2010, 70(14), 5923-5930.
123. Liu, C.; Kelnar, K.; Liu, B.; Chen, X.; Calhoun-Davis, T.; Li, H.; Patrawala, L.; Yan, H.; Jeter, C.; Honorio, S.; Wiggins, J. F.; Bader, A. G.; Fagin, R.; Brown, D.; Tang, D. G. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med., 2011, 17(2), 211-215.